Smaller OTC Loperamide Packages Wait As Retailers Limit Purchase Amounts
Executive Summary
Commissioner Scott Gottlieb updates US FDA's initiative to prevent potentially fatal abuse of OTC loperamide, noting that online and conventional retailers are limiting product purchases while the agency continues evaluating the appropriate number of doses per package.
You may also be interested in...
Perrigo's OTC Priority Shows In Launch Of Imodium Multi-Symptom Equivalent
Perrigo is launching generic of J&J’s OTC Imodium Multi-Symptom Relief product for diarrhea and gas. An analyst estimates the product could generate $15m in annualized sales.
Perrigo's OTC Priority Shows In Launch Of Imodium Multi-Symptom Equivalent
Perrigo is launching generic of J&J’s OTC Imodium Multi-Symptom Relief product for diarrhea and gas. An analyst estimates the product could generate $15m in annualized sales.
Perrigo's OTC Priority Shows In Launch Of Imodium Multi-Symptom Equivalent
Perrigo is launching generic of J&J’s OTC Imodium Multi-Symptom Relief product for diarrhea and gas. An analyst estimates the product could generate $15m in annualized sales.